All In Biotech

Drug Trial Radar · NCT06041529

Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension

An Open-Label, Superiority, Randomized, Comparative Study to Evaluate the Efficacy and Safety of Telmisartan, Amlodipine, and Chlorthalidone Fixed-Dose Combination Versus Telmisartan, Amlodipine, and Hydrochlorothiazide in Elderly Patients With Essential Hypertension Uncontrolled by Telmisartan and Amlodipine Combinations

Last checked: Nov 20, 2026Latest source record: Feb 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 198 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

198

Actual

Start

Oct 18, 2023

Primary completion

Feb 28, 2026

Study completion Feb 28, 2026

Sponsor

Lead sponsor
Yuhan CorporationIndustry
Sponsor type
Industry
First posted
Sep 18, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to compare the efficacy and safety of Telmisartan, Amlodipine, and Chlorthalidone Fixed-Dose Combination and Telmisartan, Amlodipine, and Hydrochlorothiazide in Elderly Patients with Essential Hypertension Uncontrolled by Telmisartan and Amlodipine Combinations

Conditions

  • Essential Hypertension

Interventions

  • Telmisartan/Amlodipine/Chlorthalidone 40/5/12.5 mgDrug

    PO, Once daily(QD), 8 weeks and 26 weeks if applicable

  • Telmisartan/Amlodipine/Hydrochlorothiazide 40/5/25 mgDrug

    PO, Once daily(QD), 8 weeks and 26 weeks if applicable

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Systolic Blood Pressure (MSBP) in nighttimeTime frame: Week 8

Locations

15 sites in 1 country. Site status is shown where the registry gives one.

  • Pusan National University Yangsan Hospital

    Busan, South Korea

  • The Catholic University of Korea Daejeon ST. Mary's Hospital

    Daejeon, South Korea

  • Chonnam National University Hospital

    Gwangju, South Korea

  • Gwangju Veterans Hospital

    Gwangju, South Korea

  • The Catholic University of Korea, ST. Vincent's Hospital

    Gyeonggi-do, South Korea

  • The Catholic University of Korea, Incheon ST. Mary's Hospital

    Incheon, South Korea

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    Seoul, South Korea

  • Hanyang university medical center

    Seoul, South Korea

  • The Catholic University of Korea, Seoul ST. Mary's Hospital

    Seoul, South Korea

  • The Catholic University of Korea, Yeouido ST. Mary's Hospital

    Seoul, South Korea

  • Korea University Guro Hospital

    Seoul, South Korea

  • The Catholic University of Korea, Uijeongbu ST. Mary's Hospital

    Seoul, South Korea

  • Seoul national University Budang hospital

    Seoul, South Korea

  • Wonju Severance Christian Hospital

    Wŏnju, Gangwon-do, South Korea

  • The Catholic University of Korea Bucheon St.Mary's Hospital

    Seoul, Gyeonggi-do, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.